Literature DB >> 8613057

Microwave coagulation therapy for hepatocellular carcinoma.

M Sato1, Y Watanabe, S Ueda, S Iseki, Y Abe, N Sato, S Kimura, K Okubo, M Onji.   

Abstract

BACKGROUND & AIMS: Surgical resection is not always feasible in patients with hepatocellular carcinoma. Microwave coagulation therapy has been used as an alternative to resection, and its efficacy has been evaluated.
METHODS: Nineteen patients with unresectable hepatocellular carcinoma underwent microwave coagulation therapy through laparotomy (n = 12), laparoscopy (n = 5), or thoracotomy (n = 2) because of advanced liver cirrhosis and/or intrahepatic metastases. One nodule was treated in 13 patients, tumor size ranged from 5 to 90 mm. Patient outcomes were studied.
RESULTS: Microwave coagulation therapy created a reproducible regional necrosis. Fourteen patients underwent potentially curative treatment; the remaining 5 patients underwent palliative treatment (n = 4) or incomplete tumor coagulation (n = 1). Of the 31 nodules treated, 28 underwent complete tumor ablation. Only 2 patients undergoing laparoscopic microwave coagulation therapy developed local recurrence. The coagulated area subsequently shrank. Patients showed rapid recovery without hepatic dysfunction. Thirteen patients, including 2 long-term survivors, are alive either without tumor (n = 10; 14-64 months) or with tumor (n = 3; 17-22 months). Six patients died of hepatocellular carcinoma (n = 4) or liver insufficiency (n = 2).
CONCLUSIONS: This preliminary study suggests the efficacy of microwave coagulation therapy, including safety and potential curability, in patients with hepatocellular carcinoma with advanced liver cirrhosis and multifocal or central tumors.

Entities:  

Mesh:

Year:  1996        PMID: 8613057     DOI: 10.1053/gast.1996.v110.pm8613057

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  32 in total

1.  Effects of microwave irradiation on rat hepatic tissue evaluated by enzyme histochemistry for acid phosphatase.

Authors:  Ken-ichi Mukaisho; Hiroyuki Sugihara; Tohru Tani; Yoshimasa Kurumi; Sumihiro Kamitani; Tomoki Tokugawa; Takanori Hattori
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

Review 2.  Plasmonic photothermal therapy (PPTT) using gold nanoparticles.

Authors:  Xiaohua Huang; Prashant K Jain; Ivan H El-Sayed; Mostafa A El-Sayed
Journal:  Lasers Med Sci       Date:  2007-08-03       Impact factor: 3.161

3.  Ultrasound monitoring of a novel microwave ablation (MWA) device in porcine liver: lessons learned and phenomena observed on ablative effects near major intrahepatic vessels.

Authors:  S Garrean; J Hering; A Saied; P J Hoopes; W S Helton; T P Ryan; N J Espat
Journal:  J Gastrointest Surg       Date:  2008-10-21       Impact factor: 3.452

4.  Laparoscopic microwave ablation in patients with hepatocellular carcinoma: a prospective cohort study.

Authors:  Umberto Cillo; Giulia Noaro; Alessandro Vitale; Daniele Neri; Francesco D'Amico; Enrico Gringeri; Fabio Farinati; Valter Vincenzi; Mario Vigo; Giacomo Zanus
Journal:  HPB (Oxford)       Date:  2014-04-18       Impact factor: 3.647

Review 5.  Nanoscale materials for hyperthermal theranostics.

Authors:  Bennett E Smith; Paden B Roder; Xuezhe Zhou; Peter J Pauzauskie
Journal:  Nanoscale       Date:  2015-04-28       Impact factor: 7.790

6.  Visualizing ex vivo radiofrequency and microwave ablation zones using electrode vibration elastography.

Authors:  Ryan J Dewall; Tomy Varghese; Chris L Brace
Journal:  Med Phys       Date:  2012-11       Impact factor: 4.071

Review 7.  Hepatocellular carcinoma: is current therapy really altering outcome?

Authors:  P J Johnson
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

8.  Advances and Future Directions in the Treatment of Hepatocellular Carcinoma.

Authors:  Ashil J Gosalia; Paul Martin; Patricia D Jones
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-07

9.  Clinical short-term results of radiofrequency ablation in liver cancers.

Authors:  Hong-Chi Jiang; Lian-Xin Liu; Da-Xun Piao; Jun Xu; Min Zheng; An-Long Zhu; Shu-Yi Qi; Wei-Hui Zhang; Lin-Feng Wu
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

10.  Hepatic arterial infusion chemotherapy for hepatocellular carcinoma with portal vein tumor thrombosis.

Authors:  Yung-Chih Lai; Cheng-Yen Shih; Chin-Ming Jeng; Sien-Sing Yang; Jui-Ting Hu; Yung-Chuan Sung; Han-Ting Liu; Shaw-Min Hou; Chi-Hwa Wu; Tzen-Kwan Chen
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.